HR 3539
114th Congress
House
Taxation
Drug safety, medical device, and laboratory regulation
Health technology, devices, supplies
Income tax credits
Infectious and parasitic diseases
Medical tests and diagnostic methods
Reinvigorating Antibiotic and Diagnostic Innovation Act of 2015
Introduced: September 17, 2015
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 17, 2015
Referred to the House Committee on Ways and Means.
Sep 17, 2015
Introduced in House
Plain-English summary
Reinvigorating Antibiotic and Diagnostic Innovation Act of 2015
This bill amends the Internal Revenue Code to allow tax credits for 50% of the clinical testing expenses for: (1) infectious disease products that are intended to treat a serious or life-threatening infection, including one caused by an antibacterial or antifungal resistant pathogen or a qualifying pathogen listed by the Department of Health and Human Services as having the potential to pose a serious threat to public health; and (2) in-vitro diagnostic devices that identify in less than four hours the presence, concentration, or characteristics of a serious or life-threatening infection.
What's happening now
Referred to the House Committee on Ways and Means.
Committees of jurisdiction
1